返回返回GENOR BIOPHARMA HLDGS LTD的普通股股東可獲得的稀釋淨收入。
年度數據
−3.60 B
−2.70 B
−1.80 B
−900.00 M
0.00
TTM
−568.14 M
+177.03 M
+23.76%
2023
−745.17 M
+103.98 M
+12.25%
2022
−849.15 M
+207.22 M
+19.62%
2021
−1.06 B
+2.35 B
+68.94%
2020
−3.40 B
−2.81 B
−474.59%
2019
−592.00 M
−250.78 M
−73.50%
半年度數據
H1 '21
H2 '21
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
−440.00 M
−330.00 M
−220.00 M
−110.00 M
0.00
H1 '24
−136.21 M
+295.72 M
+68.47%
H2 '23
−431.93 M
−121.42 M
−39.11%
H1 '23
−310.51 M
+50.75 M
+14.05%
H2 '22
−361.26 M
+131.72 M
+26.72%